PTSF 37
Psychedelics Today
Psychedelics Today, LLC
4.6 • 598 Ratings
🗓️ 11 December 2020
⏱️ 46 minutes
🧾️ Download transcript
Summary
In today's Solidarity Fridays episode, Kyle and Joe sit down and discuss several topics in the news.
First, they congratulate co-founder of Psymposia, President of Adelia, and friend of Psychedelics Today (and first podcast guest) Brett Greene, on Adelia being acquired by CYBIN, for the equivalent of about $15.75 million USD (!!). And they talk about Silo Pharma announcing an upcoming Phase 2B trial testing low-dose psilocybin and LSD on the effects of neurogenesis on patients with Parkinson's disease and how we often forget that psychedelics can help with physical ailments (and not just depression and anxiety), 17 healthcare professionals at TheraPsil being allowed to take psilocybin as part of a training program and the need for therapists and sitters working with psychedelics to have psychedelic experiences themselves before working with others, and rock art evidence of datura being ingested at Pinwheel Cave in California.
And they also discuss a very important article about how to keep the psychedelic renaissance from going off the rails. With so much excitement surrounding psychedelics and so many underground groups and professional organizations doing so much without any centralized control, it's too easy for people to drain their bank accounts, jump ahead of science, and overcommit to an idea, forgetting the very real risks of these substances and everything surrounding them. And if we go too far, it just raises the risk of those in power shutting it all down.
Notable Quotes
"There's a lot of nervousness around training, I think. Like, what constitutes good training? Not only is a ton of education, but it's kind of a ton of time. The same way psychoanalysts have to go through psychoanalysis themselves, and therapists have to do therapy themselves, why is it not the case that psychedelic people need to do the same?" -Joe
"I think we need to be having some of these honest conversations even if it goes against our mission here at times of wanting to help get these substances legalized, decriminalized, whatever that track is. And [talking about] the promise of it, sometimes maybe we do get idealistic and say 'This is going to revolutionize and change the world!' but I also have to think back to some of my past experiences and be like, 'Do I want to go through that again? I don't think so.' I mean, it pushed me out on the other side and I think made me a stronger person to some degree, but going through what I went through in those early years, it was pretty terrifying." -Kyle
"Education and caution, I think is the point here, moving forward, and to be really honest with yourself too, especially if you're in a place [where you're] educating folks about psychedelics. How can you listen to other people's stories and hear that maybe they're not always light and magic- that people do experience a lot of fallout from it at times and things can get worse?" -Kyle
Links
Brett Greene on Psychedelics Today (our first podcast!)
Researchgate.net: Psychedelics in Psychiatry– Keeping the Renaissance From Going Off the Rails
Snopes.com: Death of Diane Linkletter
Drugged: The Science and Culture Behind Psychotropic Drugs, by Richard J. Miller
Support the show!
- Patreon
- Leave us a review on Facebook or iTunes
- Share us with your friends
- Join our Facebook group - Psychedelics Today group – Find the others and create community.
Navigating Psychedelics
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello, everybody. Welcome back to psychedelics today, Solidarity Fridays. Today on the show, |
| 0:23.3 | Kyle and I are going to get into some fun news. How are you doing today, Kyle? Good, good. How are you |
| 0:28.2 | doing? Pretty good. I feel like it's been a while with news updates. Yeah, yeah, got sidetracked. |
| 0:36.4 | Happens. Yeah, totally, especially in this space. |
| 0:39.6 | So we wanted to, before we dig in, just mention that we have, in about a little less than a month, kick off our next two cohorts of navigating psychedelics for clinicians and therapists, eight-week program where we work you through |
| 0:54.8 | a ton of material and pretty much get you quite fluent in the space. Psychedelically literate |
| 1:02.3 | is just the beginning. You're going to be more than that. You're going to be able to understand |
| 1:07.0 | like the weird business landscape, different theoretical frameworks, harm reduction, |
| 1:13.0 | and much more. Like a lot of this stuff will, you know, easily be able to pull into your |
| 1:17.6 | clinical practice right now. Like maybe you can't throw ayahuasca at them, but maybe you can |
| 1:22.0 | use ketamine. And, you know, if you're doing a drug counseling service, like, this is pretty helpful to get actual real information. |
| 1:30.1 | So you know how to talk to your clients and patients about that stuff. |
| 1:34.0 | And anything else you want to throw in there, Kyle? |
| 1:36.0 | Now, it starts January 7th, 2 p.m. Eastern, 7 p.m. Eastern. |
| 1:41.6 | And you can learn more at psychedelic Education Center.com. Sign up. |
| 1:46.4 | All right. So let's dig in here. First off, Sybin Adelia. What do you want to say about that? |
| 1:52.5 | Yeah, I just want to give a shout out to one of our colleagues and friends, Brett Green. |
| 1:57.0 | Looks like Sybin signs a definitive agreement with, to acquire Adelia therapeutic. So |
| 2:04.0 | Brett was part of Adelia. So yeah, big shout out to him for making this happen. Yeah. |
| 2:10.9 | Yeah, it looked like a pretty big deal. So Saibin is becoming a pretty big company. And yeah, the recent acquisition of Adelia is pretty interesting. |
| 2:20.7 | I don't really have too much to say about the deal. |
| 2:23.6 | I wish I knew more about what they were manufacturing there. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Psychedelics Today, LLC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Psychedelics Today, LLC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.